Hints and tips:
Related Special Reports
...It was created from leftover scraps of fabrics and antique ties Carzana had collected, which he then hand-dyed with plants, fruits and therapeutic oils....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
...Horizon said last month that it was in takeover talks with three potential suitors, among them Johnson & Johnson and Sanofi....
...Horizon’s assets, which include treatments for chronic gout and neuromyelitis optica, a disease affecting the central nervous system, had also attracted interest from Johnson & Johnson and Sanofi....
...The company is buying Ireland-based drugmaker Horizon Therapeutics for more than $28bn, including debt....
...treatment for thyroid eye disease made by Horizon Therapeutics, since December....
...Its flagship fund, the Innovation ETF, which is dominated by holdings in electric car maker Tesla, streaming company Roku and biotech Crispr Therapeutics, appreciated by 150 per cent last year....
...Even among Tory voters the positive differential has nearly halved, shrinking from around plus-44 to (67 ‘well’ v 23 ‘badly’) in January 2020 to plus-23 (58 ‘well’ v 35 ‘badly’) today....
...Extracts from his discussion with Alix Steel and Guy Johnson: AS: Were you aware of this risk when using the platform?...
...Penny Heaton, global head of vaccines for Johnson & Johnson, said her team had begun preparing for the variant as soon as they had secured data....
...“With the thinnest ever pastry crust, the juiciest fruit, the most exact precision slicing and the most perfectly unrefined caster sugar, we have reinvented the dessert and we are calling it . . ....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...There was a March release date given for Gran Turismo 7 and the unfortunate slippage of Grand Theft Auto V from November to March. Axios has more....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...The US drugs regulator has decided to grant emergency approval in the coming days to Johnson & Johnson’s coronavirus vaccine, making it the country’s third vaccine and the first to require only a single...
...“This news makes the results from Johnson & Johnson and Novavax even more important,” he added....
...The gadget that’s got everybody talking, though, is the OPTE Precision Skincare System, launched in the US last autumn with backing from P&G Ventures and a 25,000-person waiting list....
...Mr Johnson argued that the home improvement trend had room to run....
...Rival biotech group Intellia Therapeutics plans to seek US approval for its own trial in the second half of 2020....
...on Thursday after the ride-hailing company promised profitability in the final quarter of this year, officials in London and Washington told the FT that Donald Trump vented in “apoplectic” fury at Boris Johnson...
...Johnson & Johnson, the largest healthcare company and one caught up in legal battles over the opioid crisis, has, for example, promised that its vaccine, if successful, will be produced on a “not-for-profit...
...A version of this article was first published by the Nikkei Asian Review on April 24 2020. ©2020 Nikkei Inc. All rights reserved....
...In Oklahoma, Johnson & Johnson is currently on trial for its role in the crisis — and Mr Shkolnik said that case is almost like a “trailer” for the movie that could come in October....
...“Fees are infinitesimally small because index funds have spawned competition hugely beneficial to the investor,” says Ben Johnson of Morningstar, the fund-ratings group....
International Edition